Literature DB >> 28298666

Bivalirudin as an Alternative Anticoagulant for Cardiopulmonary Bypass During Adult Cardiac Surgery-A Change in Practice.

Peter Gatt1, Samuel Anthony Galea2, Walter Busuttil3, Charles Grima1, Jeffrey Muscat1, Yvette Farrugia1.   

Abstract

The referral of patients for open heart surgery, presenting with a history of heparin hypersensitivity instigated a multidisciplinary effort to find an alternative anticoagulant to heparin. The various options mentioned in the literature call for changes in the routine practice of open heart surgery on cardiopulmonary bypass. These changes involve mostly the perfusion setup and conduct on bypass and to a lesser extent the anesthetic and surgical practice. Nevertheless, the different professions involved in the cardiac surgical firm discussed the proposed changes in a multidisciplinary effort. A new protocol was drafted, endorsed, and executed. The authors highlight these changes and their successful use in the subsequent case study.

Entities:  

Keywords:  adult cardiac surgery; anticoagulation; bivalirudin; cardiopulmonary bypass; protocol

Mesh:

Substances:

Year:  2017        PMID: 28298666      PMCID: PMC5347219     

Source DB:  PubMed          Journal:  J Extra Corpor Technol        ISSN: 0022-1058


  12 in total

1.  Successful use of bivalirudin for cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia.

Authors:  George Gordon; Hassan Rastegar; Roman Schumann; Judith Deiss-Shrem; William Denman
Journal:  J Cardiothorac Vasc Anesth       Date:  2003-10       Impact factor: 2.628

2.  Sensitivity of a modified ACT test to levels of bivalirudin used during cardiac surgery.

Authors:  Marcia L Zucker; Andreas Koster; Jayne Prats; Frank M Laduca
Journal:  J Extra Corpor Technol       Date:  2005-12

Review 3.  Bivalirudin as an adjunctive anticoagulant to heparin in the treatment of heparin resistance during cardiopulmonary bypass-assisted cardiac surgery.

Authors:  E McNair; J-A Marcoux; C Bally; J Gamble; D Thomson
Journal:  Perfusion       Date:  2015-05-01       Impact factor: 1.972

4.  Use of bivalirudin as an anticoagulant during cardiopulmonary bypass.

Authors:  James J Veale; Harry M McCarthy; George Palmer; Cornelius M Dyke
Journal:  J Extra Corpor Technol       Date:  2005-09

5.  Anticoagulant monitoring techniques in a heparin-induced thrombocytopenia patient undergoing cardiopulmonary bypass using bivalirudin anticoagulant.

Authors:  Trace Baker; Richard Chan; Fredrick Hill
Journal:  J Extra Corpor Technol       Date:  2004-12

6.  Delayed-type heparin allergy: diagnostic procedures and treatment alternatives-a case series including 15 patients.

Authors:  Claudia Pföhler; Cornelia S L Müller; Gerhard Pindur; Hermann Eichler; Hans-Joachim Schäfers; Ulrich Grundmann; Wolfgang Tilgen
Journal:  World Allergy Organ J       Date:  2008-12       Impact factor: 4.084

Review 7.  Bivalirudin.

Authors:  Theodore E Warkentin; Andreas Greinacher; Andreas Koster
Journal:  Thromb Haemost       Date:  2008-05       Impact factor: 5.249

8.  Use of bivalirudin for anticoagulation during implantation of total artificial heart.

Authors:  Myke Federman; Douglas Dragomer; Stuart Grant; Brian Reemtsen; Reshma Biniwale
Journal:  J Extra Corpor Technol       Date:  2014-06

9.  Successful implantation of a left ventricular assist device in a patient with heparin-induced thrombocytopenia and thrombosis.

Authors:  Cassandra Garland; David Somogyi
Journal:  J Extra Corpor Technol       Date:  2014-06

10.  Bivalirudin anticoagulation for cardiopulmonary bypass: an unusual case.

Authors:  Nicolas Nikolaidis; Theodore Velissaris; Sunil K Ohri
Journal:  Tex Heart Inst J       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.